Cumberland Pharmaceuticals Inc CPIX:NASDAQ

RT Quote | USD
Last | 04/18/24 EDT
1.65UNCH (UNCH)
Volume
275
52 week range
1.43 - 2.36
Loading...
  • Open1.59
  • Day High1.59
  • Day Low1.59
  • Prev Close1.65
  • 52 Week High2.36
  • 52 Week High Date01/09/24
  • 52 Week Low1.43
  • 52 Week Low Date08/08/23

Key Stats

  • Market Cap23.391M
  • Shares Out14.18M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change-11.26

KEY STATS

  • Open1.59
  • Day High1.59
  • Day Low1.59
  • Prev Close1.65
  • 52 Week High2.36
  • 52 Week High Date01/09/24
  • 52 Week Low1.43
  • 52 Week Low Date08/08/23
  • Market Cap23.391M
  • Shares Out14.18M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.17
  • YTD % Change-11.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-3.71
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.619M
  • ROE (TTM)-19.07%
  • Revenue (TTM)39.553M
  • Gross Margin (TTM)84.66%
  • Net Margin (TTM)-16.01%
  • Debt To Equity (MRQ)43.18%

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cumberland Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the...
A. Kazimi
Chairman of the Board, Chief Executive Officer
John Hamm
Chief Financial Officer, Vice President
Todd Anthony
Vice President - Organizational Development
Chris Bitterman
Vice President of Sales and Marketing
Address
2525 W End Ave Ste 950
Nashville, TN
37203-1608
United States

Top Peers

SYMBOLLASTCHG%CHG
CASI
CASI Pharmaceuticals Inc
2.25+0.01+0.57%
BFRI
Biofrontera Inc
1.70+0.03+1.80%
RVLPQ
ELUT
Elutia Inc
3.03-0.02-0.66%
NOVNQ